Autism spectrum disorder

Overview

Lifelong neurodevelopmental condition - qualitative impairments in social communication/interaction + restricted, repetitive behaviours
Prevalence ~1% in UK; male:female ratio ~3-4:1 - females frequently underdiagnosed due to camouflaging/masking
~50% of people with ASD also have a learning disability; ADHD co-occurs in 50-70%
🎯
The MMR vaccine does NOT cause autism. This originated from a fraudulent, retracted 1998 paper. A common exam distractor.

Presentation

Social communication deficits
Reduced eye contact - often earliest sign noted by parents
Delayed social smile, failure to point/share joint attention
Language delay or regression; echolalic/scripted speech
Difficulty reading non-verbal cues; impaired pretend play
Restricted, repetitive behaviours
Stereotyped repetitive movements ('stimming') - hand-flapping, rocking, spinning
Insistence on sameness; distress when routines change
Highly restricted, fixated interests
Sensory hyper- or hypo-reactivity (light, sound, texture, pain)
💡
Camouflaging (mimicking neurotypical social behaviour) is far more common in females and higher-functioning individuals - leads to diagnostic delays of years/decades and is associated with higher rates of burnout, anxiety, and depression.

Investigations

No biological test or biomarker - diagnosis is made clinically via specialist MDT assessment

🥇 First-line

referral to specialist MDT + detailed developmental history from parents/carers + cognitive/intellectual assessment + hearing and vision assessment

🏆 Gold standard

ADOS-2 (Autism Diagnostic Observation Schedule, 2nd edition) - standardised observational assessment; ADI-R (Autism Diagnostic Interview - Revised) - structured caregiver interview

🥈 Second-line

genetic testing (chromosomal microarray, Fragile X) if genetic syndrome suspected; EEG only if epilepsy clinically suspected

Differential diagnosis

Key differentials vs ASD
ConditionDistinguishing feature
ADHDInattention/impulsivity; lacks restricted interests/insistence on sameness - frequently co-occurs with ASD
Social (pragmatic) communication disorderSocial communication impairment WITHOUT restricted/repetitive behaviours - key distinction
OCDRituals are ego-dystonic and distressing; ASD restricted interests are pleasurable/self-soothing
Anxiety disorderRepetitive behaviours/social withdrawal secondary; retains social connectedness; prior period of normal function
SchizophreniaSocial withdrawal secondary to hallucinations/delusions - not a primary neurodevelopmental trait

Management

ASD cannot be cured - management aims to maximise quality of life and support development; early intensive intervention improves long-term outcomes

🥇 First-line

structured behavioural/educational intervention (as early as possible); speech and language therapy (including AAC for non-verbal individuals); psychoeducation and parent/carer support; social skills training

🥈 Second-line

pharmacological treatment of co-occurring conditions only - methylphenidate / lisdexamfetamine (ADHD); SSRIs (anxiety); melatonin (sleep); adapted CBT for anxiety/depression
⚠️
There is NO pharmacological treatment licensed for the core features of ASD in the UK. Medication targets co-occurring conditions only. Always screen for co-occurring ADHD (present in 50-70%) - it is frequently missed.

Complications

Co-occurring conditions
ADHD - 50-70%
Learning disability - ~50%
Epilepsy - up to 30% (higher with intellectual disability)
Anxiety disorders - very common; often presenting complaint in adults
Depression and OCD
Self-harm/suicidal ideation - significantly elevated, especially females diagnosed late
Sleep disorders - common across all ages
Social isolation, unemployment, educational underachievement
⚠️
Diagnostic overshadowing - attributing all symptoms to the autism diagnosis risks missing treatable co-occurring conditions such as ADHD, anxiety, and depression.